OSLI Retina

March/April 2013

Issue link: http://osliretina.healio.com/i/131340

Contents of this Issue

Navigation

Page 1 of 115

(ocriplasmin) Intravitreal Injection, 2.5 mg/mL VISIT JETREACARE.com FOR REIMBURSEMENT AND ORDERING INFORMATION ©2013 ThromboGenics, Inc. All rights reserved. ThromboGenics, Inc., 101 Wood Avenue South, Suite 610, Iselin, NJ 08830 - USA JETREA and the JETREA logo are trademarks or registered trademarks of ThromboGenics NV in the United States, European Union, Japan, and other countries. THROMBOGENICS and the THROMBOGENICS logo are trademarks or registered trademarks of ThromboGenics NV in the United States, European Union, Japan, and other countries. 03/13 OCRVMA0068 JA7

Articles in this issue

Links on this page

Archives of this issue

view archives of OSLI Retina - March/April 2013